Bob Hopkins
Stock Analyst at B of A Securities
(1.18)
# 3,445
Out of 4,711 analysts
60
Total ratings
62.22%
Success rate
-16.74%
Average return
Main Sectors:
Stocks Rated by Bob Hopkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | $220 → $255 | $187.77 | +35.80% | 5 | Nov 20, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $100 | $88.95 | +12.42% | 5 | Oct 22, 2024 | |
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $3.57 | +26.05% | 4 | Sep 13, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $48 | $81.17 | -40.86% | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $114.23 | +16.43% | 2 | Aug 31, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | $72 | $6.15 | +1,070.73% | 2 | Mar 10, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | $242 → $253 | $524.43 | -51.69% | 7 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $242.54 | - | 2 | Sep 8, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $85 → $95 | $35.91 | +164.55% | 5 | May 22, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $144.47 | - | 2 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $37 → $30 | $98.22 | -69.46% | 2 | Oct 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 → $74 | $3.79 | +1,852.51% | 5 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $105 | $81.03 | +29.58% | 7 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $83 | $29.50 | +181.36% | 6 | May 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $260 | $227.68 | +14.20% | 4 | Jan 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $82.63 | - | 1 | Nov 10, 2017 |
Inspire Medical Systems
Nov 20, 2024
Upgrades: Buy
Price Target: $220 → $255
Current: $187.77
Upside: +35.80%
Boston Scientific
Oct 22, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $88.95
Upside: +12.42%
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $3.57
Upside: +26.05%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $48
Current: $81.17
Upside: -40.86%
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $114.23
Upside: +16.43%
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: $72
Current: $6.15
Upside: +1,070.73%
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: $242 → $253
Current: $524.43
Upside: -51.69%
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $242.54
Upside: -
Tandem Diabetes Care
May 22, 2020
Maintains: Neutral
Price Target: $85 → $95
Current: $35.91
Upside: +164.55%
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $144.47
Upside: -
Oct 31, 2019
Maintains: Underperform
Price Target: $37 → $30
Current: $98.22
Upside: -69.46%
Aug 9, 2019
Reiterates: Buy
Price Target: $70 → $74
Current: $3.79
Upside: +1,852.51%
Aug 22, 2018
Maintains: Buy
Price Target: $98 → $105
Current: $81.03
Upside: +29.58%
May 22, 2018
Maintains: Buy
Price Target: $73 → $83
Current: $29.50
Upside: +181.36%
Jan 19, 2018
Reinstates: Buy
Price Target: $260
Current: $227.68
Upside: +14.20%
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $82.63
Upside: -